Fund shareholders of Co-Diagnostics Inc
ISIN US1897632048 · United States · LEI 549300Z1JPESYWFM1R93
- Fund shareholders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- 181K $
- Share of capital
- 0.9 % of 6.3M shares on Aug 11, 2026
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 58,275 | 180.7K $ | 0.00 % | 0.93 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 39 | 332.7 $ | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 2 | +1 | 58,314 | +149,423.1 % |
| 2026Q2 | 1 | 39 |
Institutional managers
13 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Private Advisory Group LLC | 41,387 | 77K $ | as of Mar 31, 2026 |
| UBS Group AG | 7,368 | 13.7K $ | as of Mar 31, 2026 |
| Smartleaf Asset Management LLC | 133 | 226 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 88 | 164 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 81 | 151 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 58 | 108 $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 50 | 85 $ | as of Mar 31, 2026 |
| Western Wealth Management, LLC | 17 | 32 $ | as of Mar 31, 2026 |
| Heritage Wealth Advisors | 17 | 32 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 10 | 18 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 7 | 13 $ | as of Mar 31, 2026 |
| HARBOUR INVESTMENTS, INC. | 2 | 4 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 2 $ | as of Mar 31, 2026 |
Declared shareholders of Co-Diagnostics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 9.99 % | 559,706 | as of Jun 30, 2026 · SCHEDULE 13G |
| JANE STREET GROUP, LLC and 2 others | 1.70 % | 89,240 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Co-Diagnostics Inc". https://titelia.com/en/stocks/co-diagnostics-inc-US1897632048